Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

Make smart decisions about your research projects.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.